BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
79 results:

  • 1. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in colorectal cancer.
    Liu J; Yue K; Yang J; Bi C; Zhang Y; Zhang W
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):53. PubMed ID: 38420805
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-term outcomes of endoscopic or surgical resection in T1 colorectal cancer patients: a retrospective cohort study.
    Song S; Dou L; Zhang Y; Liu X; Liu Y; He S; Wang G
    Surg Endosc; 2024 Mar; 38(3):1499-1511. PubMed ID: 38242989
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
    Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z
    Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes.
    Lun W; Luo C
    BMC Gastroenterol; 2023 Jul; 23(1):253. PubMed ID: 37495987
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer.
    Liu XT; Kou ZY; Zhang H; Dong J; Zhang JH; Peng YJ; Ma SM; Liang L; Meng XY; Zhou Y; Yang J
    PeerJ; 2023; 11():e15261. PubMed ID: 37151285
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's Disease.
    Dai Z; Zhang J; Xu W; Du P; Wang Z; Liu Y
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047025
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Changing trends, clinicopathological characteristics, surgical treatment patterns, and prognosis of schistosomiasis-associated versus non-schistosomiasis-associated colorectal cancer: a large retrospective cohort study of 31 153 cases in Shanghai, China (2001-2021).
    Zheng N; Wang H; Yu Q; Wang C; Bai CG; Pan AF; Jiang J; Lu J; Dai SM; Mei Z; Zhang W; Gao XH
    Int J Surg; 2023 Apr; 109(4):772-784. PubMed ID: 36999800
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Has_circ_0071803 promotes colorectal cancer progression by regulating miR-330-5p/MAPK signaling pathway.
    Huang L; Dou G; Lu J; Chen Z; Wang J
    Histol Histopathol; 2023 Dec; 38(12):1443-1451. PubMed ID: 36856372
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
    Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.
    Su YT; Chen JW; Chang SC; Jiang JK; Huang SC
    Sci Rep; 2022 Nov; 12(1):20075. PubMed ID: 36418865
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Construction of a colorectal cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
    Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
    Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The complementary role of lymphovascular invasion and perineural invasion in the TNM staging process of rectal cancer.
    Chen T; Wang M; Cheng X; Wang Y; Jiang Y; Fang X; Xiao H
    Medicine (Baltimore); 2022 Sep; 101(39):e30687. PubMed ID: 36181060
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of Foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
    Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
    BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effect of KRAS mutations and p53 expression on the postoperative prognosis of patients with colorectal cancer.
    Wang L; Lin S; Yang C; Cai S; Li W
    Mol Genet Genomic Med; 2022 Jul; 10(7):e1905. PubMed ID: 35686701
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
    Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role.
    Mulla SW; Venkatraman P
    Int J Biochem Cell Biol; 2022 May; 146():106209. PubMed ID: 35378311
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
    Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
    Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.